Typically, one of the worst pieces of news shareholders can get is that one of their stocks is opting for a secondary offering of shares that will dilute their stake in the company. While news of a secondary offering often sends a stock’s share price plummeting, Sarepta Therapeutics Inc SRPT 5.15% shares are surging 7 percent in Thursday’s session following the company’s announcement of a $225 million stock offering.

There are a number of possible reasons for this counter-intuitive move. Here are three:

• 1. Sarepta’s positive momentum is simply too strong. Sarepta has already doubled in recent weeks off of the FDA’s decision to grant accelerated approval for the company’s DMD drug eteplirsen. The stock hadn’t peaked prior to the news of the offering, and Thursday’s gain may simply be a case of the good news still outweighing the bad news.
• 2. The market expected an offering. At the very least, taking eteplirsen to market will require a sales team and a marketing initiative, neither of which come cheap. Investors may simply see the offering as a critical part of the process of getting the drug to market.
• 3. Short sellers still have not covered. The FDA’s approval of eteplirsen came as quite a surprise to the market after rival DMD drug applications by PTC Therapeutics, Inc. PTCT 6.58% and BioMarin Pharmaceutical Inc. BMRN 0.05% were rejected. The FDA even delayed…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!